Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» lung cancer
lung cancer
FDA panel says benefits outweigh risks for Lilly's lung-cancer drug
Medical Marketing and Media
Thu, 07/9/15 - 09:51 pm
FDA
advisory panels
Eli Lilly
necitumumab
lung cancer
FDA panel to discuss Lilly's lung cancer drug approval
Yahoo/Reuters
Tue, 06/2/15 - 04:57 pm
FDA
advisory panels
Eli Lilly
necitumumab
lung cancer
Bristol-Myers Slumps as Cancer Drug Trial Results Disappoint
Bloomberg
Fri, 05/29/15 - 05:50 pm
Bristol-Myers Squibb
Opdivo
lung cancer
ASCO preview: What's coming for lung cancer
Medical Marketing and Media
Tue, 05/26/15 - 04:16 pm
ASCO
lung cancer
Bristol-Myers Squibb
Merck
Roche
Keytruda
Opdivo
Roche immunotherapy improves lung cancer survival
Yahoo/Reuters
Thu, 05/14/15 - 09:51 am
Roche
lung cancer
cancer immunotherapy
MPDL3280A
Pfizer drug shows early promise in Xalkori-resistant lung cancer-study
Yahoo/Reuters
Thu, 05/14/15 - 09:49 am
Pfizer
Xalkori
lung cancer
PF-3922
How Big Can Merck's Keytruda Be In Lung Cancer?
Forbes
Tue, 04/28/15 - 09:03 pm
Merck
Keytruda
lung cancer
OncoGenex Regains Rights to Custirsen from Teva
Yahoo
Mon, 04/27/15 - 09:43 am
OncoGenex
custirsen
Teva Pharmaceutical
lung cancer
prostate cancer
Patients With Advanced Breast, Lung, Esophageal, and Colorectal Cancers Respond to Immunomedics' Novel Antibody-Directed Chemotherapy After Failing Multiple Prior Standard Treatments
Yahoo
Mon, 04/20/15 - 05:15 pm
Immunomedics
chemotherapy
breast cancer
lung cancer
esophageal cancer
colorectal cancer
sacituzumab govitecan
Merck's Keytruda shrinks lung cancer tumors, FDA approval sought
Yahoo/Reuters
Sun, 04/19/15 - 12:02 pm
Merck
Keytruda
lung cancer
FDA
non-small cell lung cancer
PDL-1 inhibitors
Bristol-Myers stops lung cancer trial after positive results
Marketwatch
Fri, 04/17/15 - 10:30 am
Opdivo
lung cancer
non-small cell lung cancer
AstraZeneca lung cancer drug delays disease by more than a year
Yahoo/Reuters
Fri, 04/17/15 - 08:37 am
AstraZeneca
AZD9291
lung cancer
In latest blow to Lilly, German court clears Actavis generics of lung cancer blockbuster
BioPharma Dive
Mon, 03/9/15 - 11:55 am
Eli Lilly
Germany
Actavis
generics
Alimta
lung cancer
Bristol-Myers Lung Cancer Drug Opdivo Wins Speedy OK
Investors.com
Wed, 03/4/15 - 05:56 pm
Opdivo
Bristol-Myers Squibb
FDA
lung cancer
cancer immunotherapy
Bristol-Myers takes a big step in its PD-1 lung cancer race with Merck
Fierce Biotech
Mon, 03/2/15 - 12:38 pm
Merck
Bristol-Myers Squibb
lung cancer
anti-PD-1 immunotherapy
Opdivo
Keytruda
Novartis lung cancer drug gets EU recommendation
Yahoo/Reuters
Fri, 02/27/15 - 09:09 am
Novartis
Europe
Zykadia
ALK inhibitors
lung cancer
Gilead's hep C star Harvoni, BMS' cancer med Opdivo lead ranks of 'exciting' launches
Fierce Pharma Marketing
Thu, 02/26/15 - 10:23 am
Gilead Sciences
Harvoni
hepatitis C
Bristol-Myers Squibb
Opdivo
melanoma
lung cancer
Bristol-Myers Checkpoint Inhibitor Prolongs Lung Cancer Patient Survival
TheStreet.com
Mon, 01/12/15 - 08:02 am
Bristol-Myers Squibb
Opdivo
lung cancer
squamous cell non-small cell lung cancer
OncoGenex to Regain Rights to Custirsen from Teva
Yahoo
Tue, 12/30/14 - 10:27 am
OncoGenex
Teva Pharmaceutical
custirsen
lung cancer
prostate cancer
FDA approves Eli Lilly’s Cyramza for lung cancer
Marketwatch
Fri, 12/12/14 - 07:23 pm
FDA
Eli Lilly
Cyramza
lung cancer
Pages
« first
‹ previous
…
9
10
11
12
13
14
15
16
17
…
next ›
last »